Shares of Torrent Pharmaceuticals Ltd. experienced fluctuations on Thursday, marking the final session for investors to purchase shares to qualify for the upcoming dividend before the stock goes ...

On Wednesday, JPMorgan updated its stance on Torrent Pharma (TRP:IN), revising the company’s price target to INR 3,650 from INR 3,700, while sustaining a Neutral stock rating. The adjustment ...

Aided by revenue growth in markets in the US, Germany and India, Torrent Pharmaceuticals, the flagship entity of Gujarat-based Torrent Group on Tuesday posted a ₹1,911 crore consolidated net ...

Its revenue jumped to Rs 2,809 crore in the third quarter compared to Rs 2,732 crore in the year-ago period, Torrent Pharma said in a statement. The company said its India revenues rose by 12 per cent ...

Torrent Pharma also disclosed that the record date for the dividend is expected to be around February 17, 2025, according to the BSE filling.

Oct 25 (Reuters) - India's Torrent Pharmaceuticals (TORP.NS), opens new tab reported a smaller-than-expected second-quarter profit on Friday, hurt by the shutdown of an insulin manufacturing facility.

Torrent Pharma has integrated one more acquisition successfully – Curatio, which is now in base year of comparison and is growing well under Torrent Pharma. The stock has rallied 78 per cent in ...

AHMEDABAD: Homegrown pharma major, Torrent Pharmaceuticals Limited (Torrent Pharma) reported a 21% increase in consolidated net profit for the June quarter (Q1 FY 2024-25) to Rs 457 crore ...

Torrent Pharmaceuticals stated on Wednesday that it has entered into a non-exclusive patent licensing deal with Takeda to commercialise Vonoprazan in India. Vonoprozan is a new potassium ...

According to Zee Business research, Torrent Pharma (TORNTPHARM) is estimated to register a consolidated net profit of Rs 447 crore for the January-March period, which translates into a jump of 56 per ...

Torrent Pharmaceuticals, one of India's top drugmakers, has said that it expects a 'new base' for its profitability going forward, given that several of its overseas operations have outgrown the ...

After an FDA inspection of a Torrent Pharmaceutical manufacturing facility in Gujarat, India, the agency has handed the company a Form 483 filing citing several production shortfalls. The ...